Literature DB >> 15748530

The metabolic effects of angiotensin-receptor blockers.

Michael L Tuck, Dalila B Corry.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15748530     DOI: 10.1007/s11906-005-0079-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  4 in total

1.  Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.

Authors:  Michael Schupp; Jürgen Janke; Ronald Clasen; Thomas Unger; Ulrich Kintscher
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

2.  Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.

Authors:  Giuseppe Derosa; Arrigo F G Cicero; Gianandrea Bertone; Mario N Piccinni; Elena Fogari; Leonardina Ciccarelli; Roberto Fogari
Journal:  Clin Ther       Date:  2004-08       Impact factor: 3.393

3.  Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.

Authors:  Kenta Okada; Tsutomu Hirano; Jianmin Ran; Mitsuru Adachi
Journal:  Hypertens Res       Date:  2004-04       Impact factor: 3.872

4.  Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.

Authors:  Harrihar A Pershadsingh; Theodore W Kurtz
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.